EUVIMEDEUVIMED entdecken
Open Access

Personalized Clostridioides difficile colonization risk prediction and probiotic therapy assessment in the human gut

Alex V Carr, Nitin S Baliga, Christian Diener, Sean M Gibbons

Cell Systems · 2025-08 · 16 (8) · 101367

DOI: 10.1016/j.cels.2025.101367 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Systems, 2025-08. Verfasst von Alex V Carr und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Systems Biology, Seattle, WA, USA; Molecular Engineering Program, University of Washington, Seattle, WA, USA. Hauptthemen laut MEDLINE: Probiotics, Clostridioides difficile, Clostridium Infections, Gastrointestinal Microbiome. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases, Austrian Science Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProbioticsClostridioides difficileClostridium InfectionsGastrointestinal MicrobiomeHumansFecal Microbiota TransplantationPrecision Medicine

Stichwörter der Autor:innen

Clostridioides difficilecolonizationcommunity-scale metabolic modelingengraftmentflux balance analysismicrobiotaprobioticsystems biology

Autor:innen und Institutionen

  • Institute for Systems Biology, Seattle, WA, USA; Molecular Engineering Program, University of Washington, Seattle, WA, USA.
  • Institute for Systems Biology, Seattle, WA, USA; Molecular Engineering Program, University of Washington, Seattle, WA, USA; Department of Biology, University of Washington, Seattle, WA, USA; Department of Microbiology,…
  • Institute for Systems Biology, Seattle, WA, USA; Diagnostic and Research Institute of Hygiene, Microbiology and Environmental Medicine, Medical University of Graz, Graz, Austria. Electronic address: christian.diener@med…
  • Institute for Systems Biology, Seattle, WA, USA; Molecular Engineering Program, University of Washington, Seattle, WA, USA; Department of Bioengineering, University of Washington, Seattle, WA, USA; Department of Genome…

Förderung

  • NIDDK NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • Austrian Science Fund
  • National Institutes of Health
  • Washington Research Foundation

Zitieren

APA

Carr, A. V., Baliga, N. S., Diener, C., & Gibbons, S. M. (2025). Personalized Clostridioides difficile colonization risk prediction and probiotic therapy assessment in the human gut. Cell Systems, 16(8), 101367. https://doi.org/10.1016/j.cels.2025.101367

Vancouver

Carr AV, Baliga NS, Diener C, Gibbons SM. Personalized Clostridioides difficile colonization risk prediction and probiotic therapy assessment in the human gut. Cell Systems. 2025;16(8):101367. doi:10.1016/j.cels.2025.101367

BibTeX
@article{Carr2025,
  author = {Carr, Alex V and Baliga, Nitin S and Diener, Christian and Gibbons, Sean M},
  title = {Personalized Clostridioides difficile colonization risk prediction and probiotic therapy assessment in the human gut},
  journal = {Cell Systems},
  year = {2025},
  volume = {16},
  number = {8},
  pages = {101367},
  doi = {10.1016/j.cels.2025.101367}
}
Kostenlos starten →